Ginkgo dry extract, refined and quantified - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

ginkgo-biloba pharma nord film-coated tablets

pharma nord aps - ginkgo biloba extract - film-coated tablet - .

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

bilobil forte

ginkgo dry extract, refined and quantified (35-67:1), extraction solvent: acetone 60% w/w1 -

Israel - English - Ministry of Health

cerebonin 120 mg

dr.samuelov importing & marketing ltd, israel - dry extract from ginkgo biloba leaves (35-67:1) - film coated tablets - dry extract from ginkgo biloba leaves (35-67:1) 120 mg - ginkgo biloba - • for the symptomatic treatment of mental losses due to organic brain syndrome within the framework of a general therapeutic concept for dementia syndromes having as major symptoms: deficient memory, disturbances of concentration, depressive mood, dizziness, tinnitus and headache.the primary target group includes patients with demential syndrome in primary degenerative dementia, vascular dementia and mixed forms of both.individual response to the treatment cannot be predicted.note: prior to starting treatment with ginkgo extract, clarification should be obtained as to whether the pathological symptoms encountered are not based on an underlying disease requiring a specific treatment.• vertigo of vascular and involutional origin.• adjuvant treatment in case of tinnitus of vascular and involutional origin.the following note for the patient is included in the instruction leaflet:“frequently occurring dizziness and tinnitus always need to be clarified by a physician. in case of sudden hearing deficit or hearing loss, you should immediately consult a physician.”